Truist Financial Issues Pessimistic Forecast for Ardent Health Partners (NYSE:ARDT) Stock Price

Ardent Health Partners (NYSE:ARDTGet Free Report) had its price objective decreased by stock analysts at Truist Financial from $22.00 to $21.00 in a research report issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. Truist Financial’s price target would indicate a potential upside of 28.44% from the company’s current price.

Several other analysts also recently issued reports on the stock. Leerink Partners boosted their target price on shares of Ardent Health Partners from $23.00 to $25.00 and gave the company an “outperform” rating in a research note on Tuesday, November 12th. Stephens reissued an “overweight” rating and issued a $24.00 price objective on shares of Ardent Health Partners in a research note on Thursday, September 19th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $20.00 target price on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Bank of America lowered shares of Ardent Health Partners from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $22.00 to $19.00 in a research report on Wednesday, November 6th. Finally, KeyCorp initiated coverage on shares of Ardent Health Partners in a research report on Friday, October 11th. They set an “overweight” rating and a $24.00 price objective on the stock. Two analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $22.00.

Get Our Latest Stock Analysis on ARDT

Ardent Health Partners Price Performance

Ardent Health Partners stock opened at $16.35 on Monday. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. Ardent Health Partners has a fifty-two week low of $14.57 and a fifty-two week high of $20.72. The stock has a 50 day moving average price of $16.66.

Institutional Investors Weigh In On Ardent Health Partners

A number of large investors have recently added to or reduced their stakes in the stock. Wellington Management Group LLP acquired a new stake in shares of Ardent Health Partners in the third quarter worth $28,724,000. Point72 Asset Management L.P. acquired a new position in Ardent Health Partners during the 3rd quarter worth $27,428,000. Goldentree Asset Management LP bought a new stake in Ardent Health Partners during the third quarter valued at about $22,897,000. Franklin Resources Inc. acquired a new stake in shares of Ardent Health Partners in the third quarter valued at about $15,839,000. Finally, Allspring Global Investments Holdings LLC bought a new position in shares of Ardent Health Partners in the third quarter worth about $13,119,000.

About Ardent Health Partners

(Get Free Report)

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

See Also

Analyst Recommendations for Ardent Health Partners (NYSE:ARDT)

Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.